Point72 Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.63M	Buy	+1,689,372	New	+$5.35M	0.01%	1758
2025 Q4	–	Sell	-2,201	Closed	-$5.83K	–	3978
2025 Q3	$5.83K	Buy	+2,201	New	+$4.26K	﹤0.01%	2259
2024 Q3	–	Sell	-67,070	Closed	-$149K	–	2087
2024 Q2	$149K	Buy	67,070 +51,000	+317%	+$120K	﹤0.01%	1662
2024 Q1	$43.1K	Buy	16,070 +11,270	+235%	+$27.4K	﹤0.01%	2070
2023 Q4	$14.4K	Sell	4,800 -3,093,052	-100%	-$4.01M	﹤0.01%	2053
2023 Q3	$3.04M	Sell	3,097,852 -1,877,148	-38%	-$2.72M	0.01%	1033
2023 Q2	$6.92M	Buy	4,975,000 +1,375,000	+38%	+$1.92M	0.02%	698
2023 Q1	$5.72M	Buy	3,600,000 +1,323,000	+58%	+$6.83M	0.02%	718
2022 Q4	$14.2M	Sell	2,277,000 -511,300	-18%	-$3.66M	0.05%	437
2022 Q3	$18.7M	Buy	2,788,300 +1,725,204	+162%	+$11.8M	0.07%	346
2022 Q2	$6.76M	Buy	+1,063,096	New	+$6.03M	0.03%	622
2021 Q2	–	Sell	-648,200	Closed	-$18.2M	–	1025
2021 Q1	$18.2M	Buy	+648,200	New	+$19.1M	0.08%	283
2020 Q1	–	Sell	-4,800	Closed	-$286K	–	866
2019 Q4	$286K	Sell	4,800 -414,590	-99%	-$18.6M	﹤0.01%	821
2019 Q3	$15.4M	Buy	419,390 +352,617	+528%	+$14M	0.09%	264
2019 Q2	$3.11M	Sell	66,773 -150,327	-69%	-$7.06M	0.02%	589
2019 Q1	$8.72M	Buy	+217,100	New	+$9.74M	0.04%	433
2018 Q4	–	Sell	-507,300	Closed	-$22.5M	–	1032
2018 Q3	$22.5M	Buy	507,300 +143,200	+39%	+$6.57M	0.09%	276
2018 Q2	$14.3M	Buy	+364,100	New	+$18.4M	0.06%	363
2015 Q4	–	Sell	-77,000	Closed	-$1.82M	–	721
2015 Q3	$1.82M	Buy	77,000 +38,200	+98%	+$2.4M	0.01%	575
2015 Q2	$3.17M	Buy	+38,800	New	+$3.8M	0.02%	520
2015 Q1	–	Sell	-10,700	Closed	-$433K	–	714
2014 Q4	$433K	Buy	+10,700	New	+$328K	﹤0.01%	618